TriangleNCT00354172 · OUTCOME
Number of Participants (Patients) With Successful Natural Killer Cell Expansion
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 10-13 Days Post Infusion
What was measured
Defined by an absolute circulating donor-derived natural killer cell count of \>100 cells/microliter 10-13 days after infusion with \<5% donor T and B cells in the mononuclear population
Groups in this outcome
Evaluable Patients
All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
| Group | Source count |
|---|---|
| Evaluable Patients | 15 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Evaluable Patients | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- anticipated Posting Date
- 2009-11
- classes
- categories
- measurements
- group Id
- OG000
- value
- 3
- denoms
- counts
- group Id
- OG000
- value
- 15
- units
- Participants
- description
- Defined by an absolute circulating donor-derived natural killer cell count of \>100 cells/microliter 10-13 days after infusion with \<5% donor T and B cells in the mononuclear population
- groups
- description
- All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
- id
- OG000
- title
- Evaluable Patients
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 10-13 Days Post Infusion
- title
- Number of Participants (Patients) With Successful Natural Killer Cell Expansion
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice